Anthology Diagnostics

Comprehensive genomic profiling enables:

- The detection and differentiation of driver and sub-clonal mutations
- Determines prognosis and identifies targeted therapies for personalized medicine
- Can be used to monitor disease and response to treatment

Learn more at: bit.ly/ADxTests

Anthology Diagnostics clinical prediction is based on our AI software. It evaluates the immunophenotype of the analyzed sample and it combines with the detected genomic abnormalities for predicting diagnosis, prognosis and clinical outcomes.

Our process:
o Use molecular profiling to comprehensively profile the disease
o We analyze both myeloid and lymphoid cells
o Search/Look for cell of origin in B-cell lymphomas
o Distinguish between myelodysplastic and acute leukemias
o Monitor the disease and detection of MRD via liquid biopsy

Learn more at bit.ly/hemeplus